Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society
Keyword(s):
2019 ◽
Vol 27
(3)
◽
pp. 992-1001
◽
2020 ◽
Vol 39
(9)
◽
pp. 517-541